Exton: West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will introduce several new, innovative pharmaceutical containment and
closure offerings at Pharmapack, February 5-6 in Paris, France. The Company expands its innovations for global customers and their patients with the introduction of two AccelTRA® component line extensions of next-generation laminated stoppers; a Flip-Off® Seal container closure system (CCS) compatible with the 5mL Daikyo Crystal Zenith® vial; and the new Ready Pack TM system with SCHOTT’s adaptiQ® platform, resulting from West’s recent partnership expansion with the leading packaging supplier.
In addition, West will share thought leadership insights into biologics and combination products, which are two priority areas in pharmaceutical packaging and delivery innovation today. Fran DeGrazio, Vice President, Scientific Affairs & Technical Services at West, will present on “Understanding the Complexities of Delivering a Biologic Drug to the Market” during the main Pharmapack session on biologics on Thursday, February 6 at 10:05 a.m. CEST.
“West’s priority is to help customers simplify their journey, whether through new products or by helping mitigate risks in the drug development process to accelerate speed to market in today’s ever-evolving, complex industry and global regulatory environment,” said DeGrazio. “We have deep knowledge of navigating the nuances of biologic drugs and delivery systems even at the earliest stages, including quality systems, design controls and risk management frameworks. By keeping a lens on the unique interface between a drug, its primary package and device, we support our customers with smart integrated solutions from end to end that help them meet, if not
exceed, industry standards.”
Company scientific and industry experts will be available at Booth #B58 to discuss West’s role in continued innovation in biologics and combination products, to provide insights into the Company’s Integrated Solutions offering, and to share additional highlights on the following new product offerings:
AccelTRA® components program: West launched two line extensions, including its
AccelTRA Select EU configurations available in Ready-to-Sterilize (RS) and Ready-to-
Use (RU) steam for customers needing a high-performing elastomer and regulatory
support in North America, as well as its AccelTRA ready-to-sterilize (RTS)/ready-to-use
(RTU) components product line with the RTS option available now for customers
needing a high-performing elastomer and lead-time program support outside North
America. Both product lines leverage the next-generation elastomer formula of 4031/45,
which features 13mm and 20mm serum and lyo stoppers in eight configurations, offering
generics customers optimal quality, speed and simplicity to help get their products to
market quickly. In addition to stoppers, the AccelTRA Select components product line
also features 1-3mL plungers for generics customers requiring a high-performing solution
for their prefilled syringe needs.
• Flip-Off® CCS Seal: The Company launched a Flip-Off CCS Seal to provide customers
with a ready-to-use sterile, superior quality capping product for its 5mL Daikyo Crystal
Zenith vial. The Flip-Off seal maintains container closure integrity and supports a safe,
convenient user experience.
• Ready PackTM system: As an expansion of West’s partnership with SCHOTT,
convenient, ready-to-use combinations of West and SCHOTT products will be available
on a small quantity basis, including West’s Ready Pack system with the SCHOTT
adaptiQ® high quality RTU glass vials. The ISO standard vial products are being offered
in three sizes: 2R; 6R; and 10R.
• Learning Lab presentation: Nico Brandes, Director, Market Development, Innovation
& Technology at West will host a Learning Lab session entitled, “Design with the End in
Mind: Patient-Centric Innovations in Containment and Delivery,” on February 6 at 11:30